A detailed history of J.P. Marvel Investment Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, J.P. Marvel Investment Advisors, LLC holds 160,074 shares of BMY stock, worth $9.18 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares
160,074
Previous 164,074 2.44%
Holding current value
$9.18 Million
Previous $6.81 Million 21.58%
% of portfolio
1.36%
Previous 1.12%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$39.66 - $51.75 $158,640 - $207,000
-4,000 Reduced 2.44%
160,074 $8.28 Million
Q2 2024

Jul 26, 2024

SELL
$40.25 - $52.99 $121,434 - $159,870
-3,017 Reduced 1.81%
164,074 $6.81 Million
Q1 2024

May 08, 2024

SELL
$47.98 - $54.4 $62,613 - $70,992
-1,305 Reduced 0.77%
167,091 $9.06 Million
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $296,891 - $354,273
-6,124 Reduced 3.51%
168,396 $8.64 Million
Q3 2023

Nov 15, 2023

SELL
$57.89 - $64.73 $251,474 - $281,187
-4,344 Reduced 2.43%
174,520 $10.1 Million
Q2 2023

Aug 10, 2023

SELL
$63.71 - $70.74 $27,204 - $30,205
-427 Reduced 0.24%
178,864 $11.4 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $5,913 - $6,707
-90 Reduced 0.05%
179,291 $12.4 Million
Q4 2022

Jan 18, 2023

SELL
$68.48 - $81.09 $5,204 - $6,162
-76 Reduced 0.04%
179,381 $0
Q3 2022

Oct 24, 2022

SELL
$0.13 - $76.84 $42 - $25,357
-330 Reduced 0.18%
179,457 $12.8 Million
Q1 2022

May 12, 2022

BUY
$61.48 - $73.72 $49,737 - $59,639
809 Added 0.45%
179,787 $13.1 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $9.6 Million - $11.2 Million
178,978 New
178,978 $11.2 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $10.8 Million - $12.6 Million
-182,488 Closed
0 $0
Q2 2021

Sep 09, 2021

BUY
$61.91 - $67.42 $3,095 - $3,371
50 Added 0.03%
182,488 $12.2 Million
Q4 2020

Sep 09, 2021

BUY
$57.74 - $65.43 $70,962 - $80,413
1,229 Added 0.68%
182,438 $11.3 Million
Q3 2020

Sep 09, 2021

SELL
$57.43 - $63.64 $14,931 - $16,546
-260 Reduced 0.14%
181,209 $10.9 Million
Q2 2020

Sep 09, 2021

SELL
$54.82 - $64.09 $2,521 - $2,948
-46 Reduced 0.03%
181,469 $10.7 Million
Q1 2020

Sep 09, 2021

BUY
$46.4 - $67.43 $52,200 - $75,858
1,125 Added 0.62%
181,515 $10.1 Million
Q4 2019

Sep 09, 2021

BUY
$49.21 - $64.19 $3.6 Million - $4.69 Million
73,118 Added 68.16%
180,390 $11.6 Million
Q3 2019

Nov 20, 2019

SELL
$42.77 - $50.71 $27,158 - $32,200
-635 Reduced 0.59%
107,272 $5.44 Million
Q1 2019

May 16, 2019

SELL
$45.12 - $53.8 $4,060 - $4,842
-90 Reduced 0.08%
107,907 $5.15 Million
Q4 2018

Feb 13, 2019

BUY
$48.76 - $63.23 $36,813 - $47,738
755 Added 0.7%
107,997 $5.61 Million
Q2 2018

Aug 15, 2018

SELL
$50.53 - $62.98 $26,275 - $32,749
-520 Reduced 0.48%
107,242 $5.94 Million
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $9,710 - $10,586
-162 Reduced 0.15%
107,762 $6.6 Million
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $1.02 Million - $1.18 Million
18,439 Added 20.61%
107,924 $6.88 Million
Q2 2017

Aug 24, 2017

BUY
N/A
89,485
89,485 $4.99 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track J.P. Marvel Investment Advisors, LLC Portfolio

Follow J.P. Marvel Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.P. Marvel Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on J.P. Marvel Investment Advisors, LLC with notifications on news.